Document Detail


Nedocromil sodium for preventing exercise-induced bronchoconstriction.
MedLine Citation:
PMID:  11869595     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Exercise-induced bronchoconstriction (EIB) following strenuous physical exertion afflicts many people. It can be the cause of sub-optimal performance, symptoms such as cough, dyspnea, wheeze and chest tightness, and can lead people to avoid physical activity. Management of EIB focuses on prevention through pharmaco-therapy and alternate strategies. Single use, pre-exercise, beta-agonists and non-steroidal antiinflammatory agents are recommended.
OBJECTIVES: Bronchodilator medications have been commonly used to prevent narrowing of airways after exercise, but anti-inflammatory drugs such as nedocromil sodium have also been used. The objective of this review was to assess the effects of a single dose of nedocromil sodium to prevent exercise-induced bronchoconstriction.
SEARCH STRATEGY: We searched the Cochrane Airways Group trials register, the Cochrane Controlled Trials Register, Current Contents, review articles, textbooks and reference lists of articles. We also contacted the drug manufacturer and primary authors for additional citations.
SELECTION CRITERIA: Randomised trials comparing a single dose of nedocromil sodium with placebo to prevent exercise-induced bronchoconstriction in patients with EIB over six years of age.
DATA COLLECTION AND ANALYSIS: Trial quality assessment and data extraction were conducted independently by two reviewers. Study authors were contacted for confirmation of data.
MAIN RESULTS: The combined results from 20 randomised controlled trials involving 280 participants, show that 4 mg, of nedocromil sodium inhaled 15 to 60 minutes prior to exercise significantly reduce the severity and duration of EIB in both adults and children, when compared to placebo. The maximum percentage fall in FEV1 was improved significantly compared to placebo (weighted mean difference 15.5 %; 95% confidence interval:13.2 to 18.1). For the maximum percentage fall in peak expiratory flow rate (PEFR) the improvement was similar: WMD 15.0%, (95% CI 8.3 to 21.6). Nedocromil shortened the time to recover lung normal function from more than 30 minutes with placebo to less than 10 minutes with the drug. It had a greater effect on those patients with more severe exercise-induced bronchoconstriction (defined as an exercise-induced fall in lung function > 30% from baseline). There were no significant adverse effects reported with the short term use of nedocromil. A further search conducted in September 2001 did not yield any further studies.
REVIEWER'S CONCLUSIONS: Nedocromil sodium used before exercise reduces the severity and duration of exercise-induced bronchoconstriction. This effect appears to be more pronounced in people with severe exercise-induced bronchoconstriction.
Authors:
C H Spooner; L D Saunders; B H Rowe
Related Documents :
10588995 - The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possi...
11504695 - Airway inflammation in nonasthmatic amateur runners.
9085535 - Changes in airway characteristics after transpalatal advancement pharyngoplasty compare...
21551475 - Rate responsive pacing using cardiac resynchronization therapy in patients with chronot...
11325685 - Intravenous l-carnitine increases plasma carnitine, reduces fatigue, and may preserve e...
16278545 - Return to play following exercise-induced bronchoconstriction.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2002  
Date Detail:
Created Date:  2002-02-28     Completed Date:  2002-05-28     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD001183     Citation Subset:  IM    
Affiliation:
Division of Emergency Medicine, University of Alberta, 1G1.52 Walter Mackenzie Health Centre, 8440 - 112 ST, Edmonton, Alberta, Canada, T6G 2B7. cspooner@ualberta.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Anti-Asthmatic Agents / therapeutic use*
Asthma, Exercise-Induced / drug therapy*
Bronchoconstriction / drug effects*
Cross-Over Studies
Humans
Middle Aged
Nedocromil / therapeutic use*
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Anti-Asthmatic Agents; 69049-73-6/Nedocromil
Comments/Corrections
Comment In:
ACP J Club. 2002 Sep-Oct;137(2):71   [PMID:  12207449 ]
Update Of:
Cochrane Database Syst Rev. 2000;(2):CD001183   [PMID:  10796616 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nerve blocks (subcostal, lateral cutaneous, femoral, triple, psoas) for hip fractures.
Next Document:  Human albumin solution for resuscitation and volume expansion in critically ill patients.